Author
Adimab (United States)ORCID 0000-0001-7704-3197Unclaimed ORCID profile · follow to get notified of new preprints
4 papers
Recent·Most cited
Meng Yuan, Brandyn R. West, William B. Foreman…·Ian A. Wilson
This paper describes VYD222, a broadly neutralizing antibody effective against SARS-CoV-2 variants, including Omicron, and explains its structural basis for resistance to viral escape.
Fanchong Jian, Anna Z. Wec, Leilei Feng…·Yunlong Cao
This paper predicts SARS-CoV-2 RBD evolution using deep mutational scanning to identify broadly neutralizing antibodies effective against existing and prospective variants.
Daniel P. Maurer, Mya L. Vu, Ana Sofia Ferreira Ramos…·Aaron G. Schmidt
The paper identifies conserved sites on influenza H1 and H3 hemagglutinin recognized by human antibodies and characterizes their neutralization potential and escape pathways.
Olivia S. Shin, Stephanie R. Monticelli, Christy K. Hjorth…·Jason S. McLellan
The paper identifies non-neutralizing antibodies from CCHFV survivors that target multiple regions on GP38, showing protective efficacy in rodent models.